Skip to main content
Fig. 7 | Stem Cell Research & Therapy

Fig. 7

From: RETRACTED ARTICLE: Polydatin improves osteogenic differentiation of human bone mesenchymal stem cells by stimulating TAZ expression via BMP2-Wnt/β-catenin signaling pathway

Fig. 7

PD inhibited OVX-induced bone loss in vivo. a Schematic images of the OVX mouse establishment and the experimental process to evaluate PD therapeutic effects. b Representative micro-CT images showed PD administration attenuated distal femoral bone loss. c Quantitative analyses of microstructure parameters, including bone volume per tissue volume (BV/TV), trabecular thickness (Tb.Th), trabecular separation (Tb.Sp), bone surface area per bone volume (BS/BV), structure model index (SMI), and trabecular number (Tb.N), n = 6 per group. Bars are shown as mean ± SD. *p < 0.05 versus the sham group; #p < 0.05 versus the OVX+PD group

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512